
    
      Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection , 20 mg:10 mL (CSPC OuYi
      Pharmaceutical Technology Co, Ltd), and CaelyxÂ®, 20 mg:10 mL (Janssen-Cilag International
      NV), in Advanced Breast Cancers.
    
  